Prospects of molybdenum and rhenium octahedral cluster complexes as X-ray contrast agents
Graphical abstract
The applicability of the hexanuclear metal cluster complexes as agents for X-ray contrast media was demonstrated. The highly radiopaque cluster cores {M6Q8} along with high tuning ability of the outer ligand environment allow creating a complex with low toxicity and rapid renal excretion.
Introduction
Since discovering of X-ray radiation in 1895 by Wilhelm C. Röentgen scientists attempted to use this new tool in medicine diagnostics [1]. To better delineate soft tissue regions the X-ray contrast agents based on heavy elements such as a silver, bismuth, barium, iodine, etc. were used [2], [3]. To date, iodinated X-ray contrast media based on 1,3,5-triiodobenzene core are among the mostly utilized pharmaceuticals for intravascular administration. However, the iodinated contrast agents have some significant disadvantages, among which cardiovascular, allergic and pain reactions [4], [5]. Also iodinated contrast media are contraindicated to patients with a history of renal insufficiency, diabetes and heart failure and with the tendency to thyroid dysfunction [6], [7], [8]. In such cases it is better to use not-iodinated X-ray contrast media containing electron-dense heavy elements like silver, tin, gadolinium, gold, thorium etc. [3], [9]. These metals can be used in different forms such as metal oxides (SnO2, ThO2, Ta2O5), nanoparticles (Ag, Au), salts (CaWO4, CsCl) and as metal chelate complexes (Gd, Yb with diethylenetriaminepentacetate (DTPA), 1,4,7-tris(carboxymethylaza)cyclododecane-10-azaacetylamide (DO3A)). Despite the rather wide variety of X-ray contrast agents, intensive investigations of new compounds with a potential to be applied as contrast agents are carrying out. The two main factors contributing to a radiopacity are electron density of a contrast agent in whole and/or atomic number of chemical elements within the agent. According to these the octahedral metal-cluster complexes [{M6Q8}L6] (M – Mo, W or Re; Q – inner halide or chalcogenide ligand; L – outer organic or inorganic ligand) are quite promising candidates for this role due to the high local concentration of heavy elements within the relatively small and very robust cluster core {M6Q8}. Unfortunately, the most of such complexes with organic outer ligands are insoluble in water that limits their use in medical applications. However, creation of appropriate outer ligand environment, for example, by ligation of the cluster core by organic molecules with polar (hydrophilic) groups, can provide water solubility of the complex.
In this contribution, preliminary comparative study of X-ray computed tomography contrast of stable water-soluble potassium salts of hexarhenium and hexamolybdenum anionic octahedral cluster complexes, namely K4[{Re6S8}(CN)6] (1), K4[{Re6Se8}(CN)6] (2), K4[{Re6Te8}(CN)6] (3), K6[{Mo6S8}(CN)6] (4), K6[{Mo6Se8}(CN)6] (5) and K2[{Mo6Br8}(CN)6] (6), K2[{Mo6I8}(CN)6] (7) is described. The cluster core {Re6Se8}2+ was selected as the most promising for creation of a new X-ray contrast agent by synthesis of a complex with outer organic ligand environment providing its solubility in water. Thus, the cytotoxicity and acute toxicity of the highly hydrophilic complex Na2H8[{Re6Se8}(P(CH2CH2CONH2)(CH2CH2COO)2)6] (8) were evaluated. In addition, a computed tomography (CT) scan experiments were carried out.
Section snippets
Materials and methods
Potassium salts of the octahedral hexarhenium cluster complexes 1–3 and hexamolybdenum cluster complexes 4 and 5 were prepared by the high-temperature reactions of the corresponding polymers Re6S8Br2, Re6Se8Br2, Re6Te15, ZnMo6S8 or Mo6Se8 with molten KCN [10], [11], [12], [13], [14].
The cluster complexes 6 and 7 were prepared according to reported methodic [15] by reactions of (Bu4N)2[{Mo6X8}(NO3)6] (X—Br or I) [16], [17] with KCN in acetone solutions.
Na4[{Re6Se8}(OH)6] was obtained by
CT-scan experiment on molybdenum and rhenium hexacyanide cluster complexes
Octahedral metal-cluster complexes with the general formula [{M6Q8}L6]n– (M—Mo, Q—halogen or chalcogen; M—Re, Q—chalcogen; L—outer ligand) contain cluster core {M6Q8}n+ with nearly regular M6 octahedron residing inside a Q8 cube. In addition, all metal atoms are coordinated by outer L ligands (Fig. 1). The cluster core consists of locally concentrated heavy elements—six metal atoms (Mo or Re) and eight inner ligands (S, Se, Te or Br, I), provide a radiopacity of octahedral metal-clusters [3].
Conclusion
To summarize, we have demonstrated the radiopacity of different cluster compounds based on {M6Q8}-cluster core (M—Mo or Re; Q—halide or chalcogenide) by the X-ray computed tomography in vitro. Despite of the highest radiopacity of the complex with {Re6Te8}-cluster core revealed, the most perspective radiocontrast agents are the {Re6Se8}-based compounds since their outer ligands can be purposefully modified allowing us to create various compounds with necessary properties. The cellular uptake
Acknowledgments
This work was supported by the Russian Science Foundation (Grant no. 14-14-00192).
References (39)
J. Am. Pharm. Assoc.
(1953)Kidney Int.
(1998)- et al.
Int. J. Cardiol.
(2005) - et al.
Kidney Int.
(2007) - et al.
Eur. J. Radiol.
(2008) - et al.
J. Struct. Biol.
(1999) - et al.
J. Inorg. Biochem.
(2008) - et al.
Eur. J. Radiol.
(2011) Sitzungsber
Phys. Med. Ges. Wurzburg
(1895)- et al.
Chem. Rev.
(1999)
Radiology
J. Am. Soc. Nephrol.
Am. J. Roentgenol.
Arch. Intern. Med.
Phys. Chem. Chem. Phys.
J. Struct. Chem.
J. Struct. Chem.
Ukr. Khim. Zh.
Chem. Eur. J.
Cited by (73)
Recent developments on luminescent octahedral transition metal cluster complexes towards biological applications
2023, Coordination Chemistry ReviewsMultitopic metal–organic carboxylates available as supramolecular building units
2023, Coordination Chemistry Reviews